About Us

Archives






Kymera Therapeutics Appoints Elaine Caughey, MBA, as Chief Business Officer

Posted: June 22, 2021 at 1:49 am


WATERTOWN, Mass., June 21, 2021 (GLOBE NEWSWIRE) -- Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing targeted protein degradation to deliver novel small molecule protein degrader medicines, today announced the appointment of Elaine Caughey, MBA, as Chief Business Officer. Ms. Caughey joins Kymera with over 20 years of experience in the biotechnology industry, including leadership roles in corporate development, business and commercial operations, new product strategy, and investing.

Read more here:
Kymera Therapeutics Appoints Elaine Caughey, MBA, as Chief Business Officer

Related Post

No Comments

No comments yet.

Sorry, the comment form is closed at this time.